QUIRK GERALD E enters SYROS PHARMACEUTICALS, INC. with 8.70K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Common Stock
Direct| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 8.70K | Direct |
| Total | 8.70K | 8.70K direct |
Stock Option (right to buy)
DirectUnderlying shares
7.50K
Shares owned
N/A
Exercise price
100.90
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying shares
4K
Shares owned
N/A
Exercise price
109.00
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying shares
6.07K
Shares owned
N/A
Exercise price
75.40
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying shares
3.72K
Shares owned
N/A
Exercise price
114.10
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying shares
14K
Shares owned
N/A
Exercise price
133.00
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying shares
6.72K
Shares owned
N/A
Exercise price
67.10
Expiration
—
Exercise window
—
Underlying
42K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock | 100.90 | — | — | 7.50K | N/A |
| Stock Option (right to buy) Direct | Common Stock | 109.00 | — | — | 4K | N/A |
| Stock Option (right to buy) Direct | Common Stock | 75.40 | — | — | 6.07K | N/A |
| Stock Option (right to buy) Direct | Common Stock | 114.10 | — | — | 3.72K | N/A |
| Stock Option (right to buy) Direct | Common Stock | 133.00 | — | — | 14K | N/A |
| Stock Option (right to buy) Direct | Common Stock | 67.10 | — | — | 6.72K | N/A |
| Total | 42K | 0.00 | ||||